| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/05/2011 | US20110104713 Products and processes for modulating peptide-peptide binding domain interactions |
| 05/05/2011 | US20110104706 Novel kinases and uses thereof |
| 05/05/2011 | US20110104315 Tetrahydroquinoline derivatives as cannabinoid receptor modulators |
| 05/05/2011 | US20110104305 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 05/05/2011 | US20110104304 O-Methylated Rapamycin Derivatives For Alleviation And Inhibition Of Lymphoproliferative Disorders |
| 05/05/2011 | US20110104301 Methods of reducing pain and inflammation |
| 05/05/2011 | US20110104296 Endorphin Therapy Compositions and Methods |
| 05/05/2011 | US20110104292 Medical composition and medical kit |
| 05/05/2011 | US20110104291 Formulation of Fine Particles Using Liquefied or Dense Gases |
| 05/05/2011 | US20110104286 Pharmaceutical compositions containing the enzyme cyprosin, an aspartic peptidase from cynara cardunculus and its inclusion in antitumour formulations |
| 05/05/2011 | US20110104283 Compositions and methods of natural products in nanoformulations for the prevention and treatment of osteoporosis |
| 05/05/2011 | US20110104279 Healing powder and method of use thereof |
| 05/05/2011 | US20110104278 Bone tissue substitute, a solidifiable bone precursor and method of making same |
| 05/05/2011 | US20110104265 Compositions and methods of targeted nanoformulations in the management of osteoporosis |
| 05/05/2011 | US20110104263 Claudin-4 binding peptides, compositions and methods of use |
| 05/05/2011 | US20110104262 Topical Combinations Comprising an Antimycotic Agent and an Antiviral Agent |
| 05/05/2011 | US20110104258 Technique for drug and gene delivery to the cell cytosol |
| 05/05/2011 | US20110104257 Polymorphisms predictive of platinum-coordinating compound-induced ototoxicity |
| 05/05/2011 | US20110104256 Methods for treating or preventing colorectal cancer |
| 05/05/2011 | US20110104252 Anti-apoptotic gene scc-s2 and diagnostic and therapeutic uses thereof |
| 05/05/2011 | US20110104251 Cosmetic Composition And Method For Retarding Hair Growth |
| 05/05/2011 | US20110104249 Oncotherapeutic Application of Inhibitors of High-Affinity Glucose Transporters |
| 05/05/2011 | US20110104246 Method of wound treatment using liquid gallium nitrate |
| 05/05/2011 | US20110104240 Nitric Oxide Device and Method for Wound Healing, Treatment of Dermatological Disorders and Microbial Infections |
| 05/05/2011 | US20110104233 Flowable composition that sets to a substantially non-flowable state |
| 05/05/2011 | US20110104228 Self-eliminating coatings |
| 05/05/2011 | US20110104227 Absorbable polyethylene diglycolate copolymers to reduce microbial adhesion to medical devices and implants |
| 05/05/2011 | US20110104225 Polypeptides, matrices, hydrogels and methods of using same for tissue regeneration and repair |
| 05/05/2011 | US20110104217 Bioactive Peptides and Method of Using Same |
| 05/05/2011 | US20110104211 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/05/2011 | US20110104207 Gyrase inhibitors and uses thereof |
| 05/05/2011 | US20110104206 Methods and compositions for sustained delivery of drugs |
| 05/05/2011 | US20110104199 MVA Expressing Modified HIV Envelope, GAG, and POL Genes |
| 05/05/2011 | US20110104189 Compositions obtained from chlorella extract having immunomodulating properties |
| 05/05/2011 | US20110104187 Method of treating glygogen storage disease |
| 05/05/2011 | US20110104184 Antibodies for inhibiting blood coagulation and methods of use thereof |
| 05/05/2011 | US20110104181 Modulation of synaptogenesis |
| 05/05/2011 | US20110104180 New vaccine for the treatment of mycobacterium related disorders |
| 05/05/2011 | US20110104179 Protease inhibitory peptides |
| 05/05/2011 | US20110104177 Histone deacetylase inhibitors, combination therapies and methods of use |
| 05/05/2011 | US20110104175 Methods of treatment for pulmonary fibrosis |
| 05/05/2011 | US20110104172 Inhibitors of gm-csf and il-17 for therapy |
| 05/05/2011 | US20110104170 Novel composition and methods for the treatment of immune related diseases |
| 05/05/2011 | US20110104169 Regulator genes of angiogenesis, pharmaceutical preparations containing them and their applications |
| 05/05/2011 | US20110104167 Compositions and Methods for Diagnosing and Treating Insulin Resistance |
| 05/05/2011 | US20110104166 Methods and Compositions for Treating Polyps |
| 05/05/2011 | US20110104165 Method of upregulating sorla for the treatment of alzheimer's disease |
| 05/05/2011 | US20110104159 Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
| 05/05/2011 | US20110104158 Deuterium bearing analogs of anastrozole as aromatase inhibitors for the treatment of breast cancer |
| 05/05/2011 | US20110104156 Methods and materials for treating autoimmune and/or complement mediated diseases and conditions |
| 05/05/2011 | US20110104152 Chimeric fibroblast growth factors with altered receptor specificity |
| 05/05/2011 | US20110104149 SingleC-9 Binding Agents |
| 05/05/2011 | US20110104146 Antithrombotic agents and methods of use thereof |
| 05/05/2011 | US20110104142 Formulations of peg-functionalised serine proteases with high concentrations of an aromatic preservative |
| 05/05/2011 | US20110104140 Use of non-catalytic form of heparanase and peptides thereof for reversing the anti-coagulant effects of heparinoids |
| 05/05/2011 | US20110104139 ANGIOSTATIC COMPOSITIONS COMPRISING TRUNCATED TYROSYL-tRNA SYNTHETASE POLYPEPTIDES AND METHODS OF USING SAME |
| 05/05/2011 | US20110104138 Use of the innate immunity gene oasl for preventing or treating infection with negative strand rna viruses |
| 05/05/2011 | US20110104136 Natural Killer p30 (NKp30) Dysfunction and the Biological Applications Thereof |
| 05/05/2011 | US20110104132 Fgf-9 and its use relating to blood vessels |
| 05/05/2011 | US20110104129 T cell receptors and related materials and methods of use |
| 05/05/2011 | US20110104118 Compositions and methods for therapeutic use |
| 05/05/2011 | US20110104116 Hsa-free formulations of interferon-beta |
| 05/05/2011 | US20110104115 Inhibitors of serine proteases, particularly hcv ns3-ns4a protease |
| 05/05/2011 | US20110104114 Polysaccharide-Protein Conjugates Reversibly Coupled Via Imine Bonds |
| 05/05/2011 | US20110104113 Ejection liquid, ejection method, method of making droplets from liquid, cartridge and ejection device |
| 05/05/2011 | US20110104112 Targeted interferons demonstrate potent apoptotic and anti-tumor activities |
| 05/05/2011 | US20110104111 Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles |
| 05/05/2011 | US20110104110 Substituted indole derivatives and methods of use thereof |
| 05/05/2011 | US20110104109 Tetracyclic indole derivatives and their use for treating or preventing viral infections |
| 05/05/2011 | US20110104108 Methods of treating cancer and other conditions or disease states using lfmau and ldt |
| 05/05/2011 | US20110104107 Compositions and methods for reducing the likelihood of preeclampsia in recipients of artificial insemination |
| 05/05/2011 | US20110104106 Compositions and methods for reducing the likelihood of preterm labor in recipients of artificial insemination |
| 05/05/2011 | US20110104104 Blockage of interferon-gamma for prevention of polymicrobial synergy |
| 05/05/2011 | US20110104103 Method of conjugating therapeutic compounds to cell targeting devices via metal complexes |
| 05/05/2011 | US20110104102 Method for stimulating mammalian cells and mammalian cell |
| 05/05/2011 | US20110104101 Immunotherapy for Unresectable Pancreatic Cancer |
| 05/05/2011 | US20110104100 Compositions and methods of stem cell therapy for autism |
| 05/05/2011 | US20110104083 Methods and cosmetic preparations for the sustained delivery of therapeutic agents to the eye |
| 05/05/2011 | US20110104074 Methods for targeted cancer treatment and detection |
| 05/05/2011 | US20110104064 Cyclized non-native synthetic peptide and complex of peptides comprising said cyclized peptide, intended to induce and to characterize the prevention or treatment of conditions in mammals |
| 05/05/2011 | US20110104059 Membrane Associated Tumor Endothelium Markers |
| 05/05/2011 | US20110104053 HUMAN IgM ANTIBODIES, AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF PARTICULARLY IN THE CENTRAL NERVOUS SYSTEM |
| 05/05/2011 | US20110104050 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin |
| 05/05/2011 | DE10311106B4 Peptide gegen Kälteunverträglichkeit hervorrufende Autoantikörper, dafür kodierende Nukleinsäuren, ihre Verwendung und diese umfassende pharmazeutische Zusammensetzungen Peptides against cold intolerance inducing autoantibodies, nucleic acids encoding, their use and pharmaceutical compositions comprising |
| 05/05/2011 | DE102009027754A1 Verfahren zur Hemmung der Reifung von dendritischen Zellen A method of inhibiting the maturation of dendritic cells |
| 05/05/2011 | DE102008053114B4 Pharmazeutischer Keratinschwamm Pharmaceutical Keratinschwamm |
| 05/05/2011 | CA2779577A1 Stabilized protein formulations and use thereof |
| 05/05/2011 | CA2779512A1 Vault complexes for cytokine delivery |
| 05/05/2011 | CA2779496A1 Analogs of pitutary adenylate cyclase-activating polypeptide (pacap) and methods for their use |
| 05/05/2011 | CA2779244A1 Dosage regimens for hcv combination therapy comprising bi201335, interferon alpha and ribavirin |
| 05/05/2011 | CA2779161A1 Yellow pea seed protein-derived peptides |
| 05/05/2011 | CA2778990A1 Macrocyclic ghrelin receptor antagonists and inverse agonists and methods of using the same |
| 05/05/2011 | CA2778890A1 Glycosylated form of antigenic glp-1 analogue |
| 05/05/2011 | CA2778759A1 Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood |
| 05/05/2011 | CA2778678A1 Improved neurturin molecules |
| 05/05/2011 | CA2778669A1 Composition to induce specific immune tolerance |
| 05/05/2011 | CA2778522A1 Nutritional compositions comprising lactoferrin and probiotics and kits of parts thereof |
| 05/05/2011 | CA2778181A1 Novel enteric combination therapy |
| 05/05/2011 | CA2777749A1 Therapeutic peptides |
| 05/05/2011 | CA2774590A1 New bacitracin antibiotics |